042520 — HANS BIOMED Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Market Cap
KR₩320bn
Enterprise Value
KR₩356bn
Revenue
KR₩90bn

Annual balance sheet for HANS BIOMED, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,268	13,553	7,048	7,259	8,149
Net Total Accounts Receivable
Net Total Receivables	9,983	10,529	13,114	12,138	17,533
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	51,113	54,371	50,393	49,707	56,072
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	46,591	46,934	44,234	43,523	41,724
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	129,445	131,686	122,368	121,715	126,407
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	60,991	74,443	65,253	50,092	81,034
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	84,994	86,052	73,239	54,841	92,703
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	44,451	45,634	49,129	66,874	33,704
Total Liabilities & Shareholders' Equity	129,445	131,686	122,368	121,715	126,407
Total Common Shares Outstanding